<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004836'>Acute promyelocytic leukemia</z:hpo> (APL) represents a biologic and clinically well-defined subtype of <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> with specific morphologic and karyotypic characteristics </plain></SENT>
<SENT sid="1" pm="."><plain>Although secondary <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are the most frequent secondary <z:hpo ids='HP_0002664'>neoplasms</z:hpo> following chemotherapy for <z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, their development after complete remission in patients with APL is uncommon </plain></SENT>
<SENT sid="2" pm="."><plain>We describe the clinical and genetic features of two APL patients who achieved CR after chemotherapy and <z:hpo ids='HP_0000001'>all</z:hpo>-trans <z:chebi fb="0" ids="26537">retinoid</z:chebi> acid treatment and subsequently developed a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1292780" disease_type="Neoplastic Process" abbrv="">Therapy-related MDS</z:e> karyotype changes such as abnormalities of chromosomes 5 and 7 were found in the cytogenetic analysis </plain></SENT>
<SENT sid="4" pm="."><plain>Since TP53 alteration was detected in one case, possible implications of these findings in the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are discussed </plain></SENT>
</text></document>